# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA644631 | Binding | Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips; No data | 1 | ALA1128669 | single protein format | Scientific Literature | ||
2. | ALA841410 | Functional | Inhibition of arachidonic acid (AA) induced human platelet aggregation. | Homo sapiens | 25 | ALA1125545 | organism-based format | Scientific Literature | |
3. | ALA845331 | Binding | Nitric oxide released from prodrug in the absence of cysteine | 17 | ALA1129936 | assay format | Scientific Literature | ||
4. | ALA845333 | Binding | Nitric oxide released from prodrug in the presence of cysteine | 17 | ALA1129936 | assay format | Scientific Literature | ||
5. | ALA1909163 | Binding | DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4) | Cavia porcellus | 871 | ALA1909046 | tissue-based format | DrugMatrix | |
6. | ALA1909164 | Binding | DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
7. | ALA1909165 | Binding | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | Oryctolagus cuniculus | 871 | ALA1909046 | tissue-based format | DrugMatrix | |
8. | ALA1909166 | Binding | DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
9. | ALA1909167 | Binding | DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
10. | ALA1909168 | Binding | DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
11. | ALA1909169 | Binding | DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) | 871 | ALA1909046 | cell-based format | DrugMatrix | ||
12. | ALA1909170 | Binding | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
13. | ALA1909171 | Binding | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
14. | ALA1909172 | Binding | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
15. | ALA1909173 | Binding | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
16. | ALA1909174 | Binding | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
17. | ALA1909175 | Binding | DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
18. | ALA1909176 | Binding | DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
19. | ALA1909177 | Binding | DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
20. | ALA1909178 | Binding | DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine) | Rattus norvegicus | 871 | ALA1909046 | tissue-based format | DrugMatrix |